Arthritis drug sparks notable hair regrowth in alopecia trials
An oral arthritis medication called upadacitinib demonstrated substantial hair regrowth in two international trials for severe alopecia areata, with about half of participants achieving at least 80% scalp coverage after 24 weeks; some reached complete restoration. While promising, results vary by patient and longer-term effects and safety still need assessment.